Preovidlen 70 mg Tablet
PDF Leaflet Revision Date: 25 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of post-menopausal osteoporosis to reduce fracture risk.
Dosage (summary)
One tablet (70 mg/5600 IU) once weekly.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not for use in pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- Food and beverages reduce absorption
- NSAIDs may increase gastrointestinal irritation
Contraindications
- Hypersensitivity to components
- Oesophageal abnormalities
- Inability to sit upright
- Hypocalcaemia
- Severe renal insufficiency
- Pregnancy
- Breastfeeding
Common side effects
- Abdominal pain
- Dyspepsia
- Oesophageal ulcer
- Dysphagia
Counselling Points
- Take with plain water, 30 mins before food
- Do not lie down for 30 mins after taking
- Report any signs of oesophageal irritation
Serious warnings
- Risk of oesophageal irritation
- Osteonecrosis of the jaw
- Atypical femur fractures
Important Disclaimer
The Preovidlen 70 mg Tablet professional information leaflet below is the property of Pharmacare Limited and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
